AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Carithers, RL
Citation: Rl. Carithers, Epidemiology of hepatitis B and hepatitis C, CLIN GAS, 2002, pp. 25-40

Authors: Larson, AM Carithers, RL
Citation: Am. Larson et Rl. Carithers, Hepatitis C in clinical practice, J INTERN M, 249(2), 2001, pp. 111-120

Authors: Carr, DB Larson, AM Schmucker, BC Brateng, DA Carithers, RL Easterling, TR
Citation: Db. Carr et al., Maternal hemodynamics and pregnancy outcome in women with prior orthotopicliver transplantation, LIVER TRANS, 6(2), 2000, pp. 213-221

Authors: Carithers, RL
Citation: Rl. Carithers, Liver transplantation, LIVER TRANS, 6(1), 2000, pp. 122-135

Authors: Cotler, SJ Wartelle, CF Larson, AM Gretch, DR Jensen, DM Carithers, RL
Citation: Sj. Cotler et al., Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C, J VIRAL HEP, 7(3), 2000, pp. 211-217

Authors: Carithers, RL Marquardt, A Gretch, DR
Citation: Rl. Carithers et al., Diagnostic testing for hepatitis C, SEM LIV DIS, 20(2), 2000, pp. 159-171

Authors: Chang, M Marquardt, AP Wood, BL Williams, O Cotler, SJ Taylor, SL Carithers, RL Gretch, DR
Citation: M. Chang et al., In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease, J VIROLOGY, 74(2), 2000, pp. 944-955

Authors: Nousbaum, JB Polyak, SJ Ray, SC Sullivan, DG Larson, AM Carithers, RL Gretch, DR
Citation: Jb. Nousbaum et al., Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy, J VIROLOGY, 74(19), 2000, pp. 9028-9038

Authors: Polyak, SJ Nousbaum, JB Larson, AM Cotler, S Carithers, RL Gretch, DR
Citation: Sj. Polyak et al., The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon, J INFEC DIS, 182(2), 2000, pp. 397-404

Authors: Cotler, SJ Taylor, SL Gretch, DR Bronner, MP Rizk, R Perkins, JD Carithers, RL
Citation: Sj. Cotler et al., Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients, AM J GASTRO, 95(3), 2000, pp. 753-759

Authors: Combes, B Markin, RS Wheeler, DE Rubin, R West, AB Mills, AS Eigenbrodt, EH Maddrey, WC Munoz, SJ Garcia-Tsao, G Bonner, GF Boyer, JL Luketic, VA Shiffman, ML Peters, MG White, HM Zetterman, RK Carithers, RL
Citation: B. Combes et al., The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis, HEPATOLOGY, 30(3), 1999, pp. 602-605

Authors: Combes, B Carithers, RL Maddrey, WC Munoz, S Garcia-Tsao, G Bonner, GF Boyer, JL Luketic, VA Shiffman, ML Peters, MG White, H Zetterman, RK Risser, R Rossi, SS Hofmann, AF
Citation: B. Combes et al., Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholicacid, HEPATOLOGY, 29(6), 1999, pp. 1649-1654

Authors: Shuhart, RC Carithers, RL
Citation: Rc. Shuhart et Rl. Carithers, Hepatitis, CLINICAL INFECTIOUS DISEASES, 1999, pp. 589-596

Authors: Larson, AM Carithers, RL
Citation: Am. Larson et Rl. Carithers, Management of alcoholic liver disease, CLIN G MED, 1999, pp. 181-198

Authors: Cotler, SJ Gaur, LK Wile, M Strong, DM Bronner, MP Carithers, RL Emond, MJ Perkins, JD Nelson, KA
Citation: Sj. Cotler et al., Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation, TISSUE ANTI, 52(5), 1998, pp. 435-443
Risultati: 1-15 |